Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126589201 | 12658920 | 1 | I | 20160803 | 20160817 | 20160817 | EXP | RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-122210 | RANBAXY | BARBILIAN A, PRELIPCEANU D. RESISTANT PSYCHOSIS IN A PATIENT WITH COEXISTING BETA-THALASSEMIA AND LATENT TOXOPLASMOSIS. ROMANIAN JOURNAL OF PSYCHIATRY. 2016;XVIII NO. 2:55-58 | 44.00 | YR | M | Y | 0.00000 | 20160817 | MD | RO | RO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126589201 | 12658920 | 1 | PS | OLANZAPINE. | OLANZAPINE | 1 | Unknown | UNK | U | U | 91038 | ||||||||
| 126589201 | 12658920 | 2 | SS | CLOZAPINE. | CLOZAPINE | 1 | Unknown | 300 MG, DAILY | Y | U | 0 | 300 | MG | ||||||
| 126589201 | 12658920 | 3 | SS | CLOZAPINE. | CLOZAPINE | 1 | Unknown | 500 MG, DAILY | Y | U | 0 | 500 | MG | ||||||
| 126589201 | 12658920 | 4 | SS | CLOZAPINE. | CLOZAPINE | 1 | Unknown | 150 MG, DAILY | Y | U | 0 | 150 | MG | ||||||
| 126589201 | 12658920 | 5 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126589201 | 12658920 | 6 | SS | Thioproperazine | THIOPROPERAZINE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126589201 | 12658920 | 7 | SS | Levomepromazine | LEVOMEPROMAZINE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126589201 | 12658920 | 8 | SS | Levomepromazine | LEVOMEPROMAZINE | 1 | Unknown | 50 MG, DAILY | U | U | 0 | 50 | MG | ||||||
| 126589201 | 12658920 | 9 | SS | ALPRAZOLAM. | ALPRAZOLAM | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126589201 | 12658920 | 10 | SS | HALOPERIDOL. | HALOPERIDOL | 1 | Unknown | 15-20 MG/DAY | U | U | 0 | ||||||||
| 126589201 | 12658920 | 11 | SS | Trihexyphenidyl | TRIHEXYPHENIDYL | 1 | Unknown | 4 MG, DAILY | U | U | 0 | 4 | MG | ||||||
| 126589201 | 12658920 | 12 | SS | DIAZEPAM. | DIAZEPAM | 1 | Unknown | 10 MG, UNK | U | U | 0 | 10 | MG | ||||||
| 126589201 | 12658920 | 13 | SS | DIAZEPAM. | DIAZEPAM | 1 | Unknown | 20 MG, DAILY | U | U | 0 | 20 | MG | ||||||
| 126589201 | 12658920 | 14 | SS | Leponex | CLOZAPINE | 1 | Unknown | 200 MG, UNK | U | U | 0 | 200 | MG | ||||||
| 126589201 | 12658920 | 15 | SS | Leponex | CLOZAPINE | 1 | Unknown | 300 MG, DAILY | U | U | 0 | 300 | MG | ||||||
| 126589201 | 12658920 | 16 | SS | Amisulpride | AMISULPRIDE | 1 | Unknown | 500 MG, DAILY | U | U | 0 | 500 | MG | ||||||
| 126589201 | 12658920 | 17 | SS | Amisulpride | AMISULPRIDE | 1 | Unknown | 800 MG, DAILY | U | U | 0 | 800 | MG | ||||||
| 126589201 | 12658920 | 18 | SS | Amisulpride | AMISULPRIDE | 1 | Unknown | 1000 MG, DAILY | U | U | 0 | 1000 | MG | ||||||
| 126589201 | 12658920 | 19 | SS | Amisulpride | AMISULPRIDE | 1 | UNK | U | U | 0 | |||||||||
| 126589201 | 12658920 | 20 | SS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | Unknown | 30 MG, DAILY | U | U | 0 | 30 | MG | ||||||
| 126589201 | 12658920 | 21 | SS | VALPROIC ACID. | VALPROIC ACID | 1 | Unknown | 1000 MG, DAILY | U | U | 0 | 1000 | MG | ||||||
| 126589201 | 12658920 | 22 | SS | FLUPENTHIXOL DECANOATE DEPOT | FLUPENTIXOL DECANOATE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126589201 | 12658920 | 23 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126589201 | 12658920 | 1 | Schizophrenia |
| 126589201 | 12658920 | 2 | Schizophrenia |
| 126589201 | 12658920 | 5 | Schizophrenia |
| 126589201 | 12658920 | 6 | Schizophrenia |
| 126589201 | 12658920 | 7 | Schizophrenia |
| 126589201 | 12658920 | 9 | Schizophrenia |
| 126589201 | 12658920 | 10 | Schizophrenia |
| 126589201 | 12658920 | 11 | Schizophrenia |
| 126589201 | 12658920 | 12 | Product used for unknown indication |
| 126589201 | 12658920 | 14 | Schizophrenia |
| 126589201 | 12658920 | 16 | Schizophrenia |
| 126589201 | 12658920 | 20 | Schizophrenia |
| 126589201 | 12658920 | 21 | Schizophrenia |
| 126589201 | 12658920 | 22 | Schizophrenia |
| 126589201 | 12658920 | 23 | Thalassaemia beta |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126589201 | 12658920 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126589201 | 12658920 | Confusional state | |
| 126589201 | 12658920 | Drug effect incomplete | |
| 126589201 | 12658920 | Generalised tonic-clonic seizure | |
| 126589201 | 12658920 | Loss of consciousness | |
| 126589201 | 12658920 | Muscle disorder | |
| 126589201 | 12658920 | Psychotic disorder | |
| 126589201 | 12658920 | Scapula fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126589201 | 12658920 | 3 | 201501 | 0 | ||
| 126589201 | 12658920 | 7 | 201501 | 0 | ||
| 126589201 | 12658920 | 9 | 201501 | 0 | ||
| 126589201 | 12658920 | 13 | 20150602 | 0 | ||
| 126589201 | 12658920 | 15 | 20150602 | 0 | ||
| 126589201 | 12658920 | 16 | 20150602 | 0 |